Ubs Asset Management Americas Inc Incyte Corp Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Incyte Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,970,652 shares of INCY stock, worth $172 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,970,652
Previous 1,583,116
24.48%
Holding current value
$172 Million
Previous $95.9 Million
40.0%
% of portfolio
0.03%
Previous 0.03%
Shares
31 transactions
Others Institutions Holding INCY
# of Institutions
730Shares Held
202MCall Options Held
516KPut Options Held
265K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.68 Billion21.22% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.86 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.1MShares$1.76 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.6MShares$1.27 Billion0.6% of portfolio
-
State Street Corp Boston, MA9.88MShares$861 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $19.4B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...